Patent · US Active

Azalactam compounds as HPK1 inhibitors

US11684616B2 · kind B2 · utility

0Cited by
0References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2021
Grant dateJun 27, 2023
Priority date
Expiry dateAug 11, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to compounds of general Formula I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.